TR199700369A2 - S�lfonamid ile s�bstit�e edilmi� kroman'lar, bunlar�n �retilmesine mahsus usul, ila� veya diyagnostik olarak kullan�lmalar� ve bunlar� i�eren ila�. - Google Patents
S�lfonamid ile s�bstit�e edilmi� kroman'lar, bunlar�n �retilmesine mahsus usul, ila� veya diyagnostik olarak kullan�lmalar� ve bunlar� i�eren ila�.Info
- Publication number
- TR199700369A2 TR199700369A2 TR97/00369A TR9700369A TR199700369A2 TR 199700369 A2 TR199700369 A2 TR 199700369A2 TR 97/00369 A TR97/00369 A TR 97/00369A TR 9700369 A TR9700369 A TR 9700369A TR 199700369 A2 TR199700369 A2 TR 199700369A2
- Authority
- TR
- Turkey
- Prior art keywords
- production
- medicine
- treatment
- sulfonamide
- diagnostics
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 5
- 150000001843 chromanes Chemical class 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 230000002861 ventricular Effects 0.000 abstract 2
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 210000001198 duodenum Anatomy 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19619614A DE19619614A1 (de) | 1996-05-15 | 1996-05-15 | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE1996139462 DE19639462A1 (de) | 1996-09-26 | 1996-09-26 | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199700369A2 true TR199700369A2 (xx) | 1997-12-21 |
Family
ID=26025736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR97/00369A TR199700369A2 (xx) | 1996-05-15 | 1997-05-13 | S�lfonamid ile s�bstit�e edilmi� kroman'lar, bunlar�n �retilmesine mahsus usul, ila� veya diyagnostik olarak kullan�lmalar� ve bunlar� i�eren ila�. |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0807629B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4234798B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100547921B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1204134C (cg-RX-API-DMAC7.html) |
| AR (2) | AR007115A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE260909T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU711986B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR9703161A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2205477A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ149497A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE59711352D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0807629T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2218617T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP970255B1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP9700903A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL120827A (cg-RX-API-DMAC7.html) |
| NO (1) | NO315556B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ314800A (cg-RX-API-DMAC7.html) |
| PL (1) | PL191330B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT807629E (cg-RX-API-DMAC7.html) |
| SK (1) | SK283837B6 (cg-RX-API-DMAC7.html) |
| TR (1) | TR199700369A2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW496866B (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ329200A (en) * | 1996-12-16 | 1999-05-28 | Hoechst Ag | Sulphonamide substituted quinazoline, isoquinoline, quinoline or benzo[1,3-]oxazine derivatives and medicaments |
| DE19705133A1 (de) * | 1997-02-11 | 1998-08-13 | Hoechst Ag | Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19706675A1 (de) * | 1997-02-20 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0895994A3 (de) * | 1997-08-05 | 1999-12-15 | Hoechst Marion Roussel Deutschland GmbH | Sulfonamid-substituierte Pyranopyridine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19742509A1 (de) * | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
| DE19742508A1 (de) | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
| DE19748469A1 (de) * | 1997-11-03 | 1999-05-06 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| JP2002523451A (ja) | 1998-09-01 | 2002-07-30 | ブリストル−マイヤーズ スクイブ カンパニー | カリウムチャネル抑制剤および方法 |
| DE19858253A1 (de) | 1998-12-17 | 2000-06-21 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
| US7368582B2 (en) | 2003-10-17 | 2008-05-06 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| PL1732929T3 (pl) * | 2004-03-23 | 2011-04-29 | Nissan Chemical Ind Ltd | Związek benzopiranowy jako środek przeciw-arytmiczny |
| US7884109B2 (en) | 2005-04-05 | 2011-02-08 | Wyeth Llc | Purine and imidazopyridine derivatives for immunosuppression |
| US7989459B2 (en) | 2006-02-17 | 2011-08-02 | Pharmacopeia, Llc | Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| US7902187B2 (en) | 2006-10-04 | 2011-03-08 | Wyeth Llc | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| CL2007002867A1 (es) | 2006-10-04 | 2008-06-27 | Pharmacopeia Inc | Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras. |
| WO2008043031A1 (en) | 2006-10-04 | 2008-04-10 | Pharmacopeia, Inc. | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| SG175377A1 (en) * | 2009-04-30 | 2011-12-29 | Nissan Chemical Ind Ltd | Novel crystal forms of tricyclic benzopyran compound and processes for producing same |
| TWI583677B (zh) | 2012-09-21 | 2017-05-21 | 日本臟器製藥股份有限公司 | 香豆素衍生物 |
| CN103012380B (zh) * | 2013-01-10 | 2015-03-04 | 山东大学 | 一种色满类化合物及其制备方法与应用 |
| JP6089055B2 (ja) * | 2014-03-20 | 2017-03-01 | 日本臓器製薬株式会社 | クマリン誘導体を含有する医薬 |
| AR117169A1 (es) | 2018-11-28 | 2021-07-14 | Bayer Ag | (tio)amidas de piridazina como compuestos fungicidas |
| WO2021224220A1 (en) | 2020-05-06 | 2021-11-11 | Bayer Aktiengesellschaft | Pyridine (thio)amides as fungicidal compounds |
| BR112022023012A2 (pt) | 2020-05-12 | 2022-12-20 | Bayer Ag | (tio)amidas de triazina e pirimidina como compostos fungicidas |
| BR112022023550A2 (pt) | 2020-05-19 | 2023-01-03 | Bayer Cropscience Ag | (tio)amidas azabicíclicas como compostos fungicidas |
| JP7760531B2 (ja) | 2020-05-27 | 2025-10-27 | バイエル、アクチエンゲゼルシャフト | 活性化合物の組合せ物 |
| JP2024540323A (ja) | 2021-11-03 | 2024-10-31 | バイエル、アクチエンゲゼルシャフト | 殺菌性化合物としてのビス（ヘテロ）アリールチオエーテル（チオ）アミド |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
-
1997
- 1997-05-13 SK SK603-97A patent/SK283837B6/sk unknown
- 1997-05-13 CN CNB971115400A patent/CN1204134C/zh not_active Expired - Fee Related
- 1997-05-13 HR HR970255A patent/HRP970255B1/xx not_active IP Right Cessation
- 1997-05-13 TW TW086106326A patent/TW496866B/zh not_active IP Right Cessation
- 1997-05-13 EP EP97107775A patent/EP0807629B1/de not_active Expired - Lifetime
- 1997-05-13 AR ARP970101998A patent/AR007115A1/es not_active Application Discontinuation
- 1997-05-13 AU AU20806/97A patent/AU711986B2/en not_active Ceased
- 1997-05-13 AT AT97107775T patent/ATE260909T1/de not_active IP Right Cessation
- 1997-05-13 DK DK97107775T patent/DK0807629T3/da active
- 1997-05-13 ES ES97107775T patent/ES2218617T3/es not_active Expired - Lifetime
- 1997-05-13 PT PT97107775T patent/PT807629E/pt unknown
- 1997-05-13 TR TR97/00369A patent/TR199700369A2/xx unknown
- 1997-05-13 DE DE59711352T patent/DE59711352D1/de not_active Expired - Lifetime
- 1997-05-13 NZ NZ314800A patent/NZ314800A/xx unknown
- 1997-05-14 NO NO19972211A patent/NO315556B1/no unknown
- 1997-05-14 IL IL12082797A patent/IL120827A/en not_active IP Right Cessation
- 1997-05-14 CZ CZ971494A patent/CZ149497A3/cs unknown
- 1997-05-14 BR BR9703161A patent/BR9703161A/pt not_active Application Discontinuation
- 1997-05-14 JP JP13798497A patent/JP4234798B2/ja not_active Expired - Fee Related
- 1997-05-15 HU HU9700903A patent/HUP9700903A3/hu unknown
- 1997-05-15 CA CA002205477A patent/CA2205477A1/en not_active Abandoned
- 1997-05-15 PL PL319995A patent/PL191330B1/pl unknown
- 1997-05-15 KR KR1019970018635A patent/KR100547921B1/ko not_active Expired - Fee Related
- 1997-11-26 AR ARP970105574A patent/AR010314A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199700369A2 (xx) | S�lfonamid ile s�bstit�e edilmi� kroman'lar, bunlar�n �retilmesine mahsus usul, ila� veya diyagnostik olarak kullan�lmalar� ve bunlar� i�eren ila�. | |
| ATE71293T1 (de) | Arzneiformulierung. | |
| NO172344C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter | |
| ATE102930T1 (de) | Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend. | |
| TR200001542T2 (tr) | Mide fundusunu gevşetici özelliklere sahip (benzodioksan, benzofuran veya benzopiran) türevleri. | |
| ATE123944T1 (de) | Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen. | |
| DE69131907D1 (de) | Thienodiazepinverbindungen und ihre verwendung | |
| ZA934740B (en) | Treatment of inflammatory bowel disease | |
| ATE114154T1 (de) | Thienotriazolodiazepine und ihre pharmazeutische verwendung. | |
| KR950013513A (ko) | 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제 | |
| TR199800301A2 (xx) | S�lfonamid-substit�e edilmi� 7 halkal� bile�ikler. | |
| NO165195C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler. | |
| ES8301212A1 (es) | Procedimiento para la preparacion de derivados de prostaciclina. | |
| ATE70182T1 (de) | Therapeutische mittel zur behandlung von magengeschwueren. | |
| FI883745A0 (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel. | |
| GB9902989D0 (en) | Heterocyclic derivatives | |
| Nelson et al. | Disseminated Mycobacterium chelonae ssp. abscessus in an immunocompetent host and with a known portal of entry | |
| TR199800195A2 (xx) | Sulfonamid-ikame edilmi� bile�ikler, bunlar�n imalat usul�. | |
| DK360388A (da) | Laegemiddel til behandling af hjerteinsufficiens | |
| ATE91890T1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| WO2003024957A1 (en) | Benzimidazole derivatives | |
| DE3888284D1 (de) | Arzneimittel, darin enthaltene phosphorhaltige 2-Isoxazoline und Isoxazole, sowie Herstellungsverfahren für diese heterocyclischen Verbindungen. | |
| ATE124398T1 (de) | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung. | |
| Gomi et al. | Controlled clinical trial with minocycline in two dosage schedule in respiratory infectious diseases | |
| Khanna et al. | Povidone-iodine (Betadine) as prophylaxis against wound infection in abdominal tubal ligation |